DNA vaccination against Theiler's murine encephalomyelitis virus leads to alterations in demyelinating disease

Journal of Virology

Volumn 73, Issue 2, 1999, Pages 993-1000

  Tolley, Neal D ^a   Tsunoda, Ikuo ^a   Fujinami, Robert S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; DNA VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL PARASITOSIS; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEMYELINATION; FEMALE; IMMUNIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PLASMID; PRIORITY JOURNAL; VIRUS CAPSID;

EID: 0032903488     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.2.993-1000.1999     Document Type: Article

References (53)

1. Barnett, L. A., J. L. Whilton, Y. Wada, and R. S. Fujinami. 1993. Enhancement of autoimmune disease using recombinant vaccinia virus encoding myelin proteolipid protein. J. Neuroimmunol. 44:15-25. (Erratum, 48:120.)
2. Bradley, W. G., R. B. Daroff, G. M. Fenichel, and C. D. Marsden. 1996. Neurology in clinical practice, p. 1307-1343. Butterworth-Heinemann, Newton, Mass.
3. Compston, D. A., W. H. Kellar, N. Robertson, S. Sawcer, and N. W. Wood. 1995. Genes and susceptibility to multiple sclerosis. Acta Neurol. Scand. Suppl. 161:43-51.
4. Cook, S. D., K. C. Rohowsky, S. Bansil, and P. C. Dowling. 1995. Evidence for multiple sclerosis as an infectious disease. Acta Neurol. Scand. Suppl. 161:34-42.
5. Corr, M., D. J. Lee, D. A. Carson, and H. Tighe. 1996. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med. 184:1555-1560.
6. Fujinami, R. S. 1990. Viruses and autoimmunity, p. 77-82. In M. H. V. van Regenmortel and A. R. Neurath (ed.), Immunochemistry of viruses. II. The basis for serodiagnosis and vaccines. Elsevier Science Publishers B.V., Amsterdam, The Netherlands.
7. Fujinami, R. S., and A. Zurbriggen. 1989. Is Theiler's murine encephalomyelitis virus infection of mice an autoimmune disease? APMIS 97:1-8.
8. Fujinami, R. S., A. Zurbriggen, and H. C. Powell. 1988. Monoclonal antibody defines determinant between Theiler's virus and lipid-like structures. J. Neuroimmunol. 20:25-32.
9. Fuller, D. H., and J. R. Haynes. 1994. A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine. AIDS Res. Hum. Retroviruses 10:1433-1441.
10. Gerety, S. J., W. J. Karpus, A. R. Cubbon, R. G. Goswami, M. K. Rundell, J. D. Peterson, and S. D. Miller. 1994. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice. J. Immunol. 152:908-918.
11. Gerety, S. J., M. K. Rundell, M. C. Dal Canto, and S. D. Miller. 1994. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potntiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope. J. Immunol. 152:919-929.
12. Goodkin, D. E. 1994. Role of steroids and immunosuppression and effects of interferon beta-1 in multiple sclerosis. West. J. Med. 161:292-298.
13. Haegert, D. G., and M. G. Marrosu. 1994. Genetic susceptibility to multiple sclerosis. Ann. Neurol. 36(Suppl. 2):S204-S210.
14. Hafler, D. A. 1997. Recognition of self antigens in multiple sclerosis, p. 71-79. In O. Abramsky and H. Ovadia (ed.), Frontiers in multiple sclerosis: clinical research and therapy. Mosby-Year Book, St. Louis, Mo.
15. Hartung, H. P. 1997. Pathogenesis of multiple sclerosis, p. 45-59. In O. Abramsky and H. Ovadia (ed.), Frontiers in multiple sclerosis: clinical research and therapy. Mosby-Year Book, St. Louis, Mo.
16. Hassett, D. E., and J. L. Whitton. 1996. DNA immunization. Trends Microbiol. 4:307-312.
17. Hillert, J. 1994. Human leukocyte antigen studies in multiple sclerosis. Ann. Neurol. 36(Suppl.):S15-S17.
18. Inou, A., Y. K. Choe, and B. S. Kim 1994. Analysis of antibody responses to predominant linear epitopes of Theiler's murine encephalomyelitis virus. J. Virol. 68:3324-3333.
19. Iwasaki, A., C. A. Torres, P. S. Ohashi, H. L. Robinson, and B. H. Barber. 1997. The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J. Immunol. 159:11-14.
20. Kurtz, C. I. B., X. Sun, and R. S. Fujinami. 1995. Protection of SJL/J mice from demyelinating disease mediated by Theiler's murine encephalomyelitis virus. Microb. Pathog. 18:11-27.
21. Kurtzke, J. F., G. W. Beebe, and J. E. Norman. 1979. Epidemiology of multiple sclerosis in U.S. veterans. 1. Race, sex, and geographic distribution. Neurology 29:1228-1235.
22. Lin, X., N. R. Thiemann, L. R. Pease, and M. Rodriguez. 1995. VP1 and VP2 capsid proteins of Theiler's virus are targets of H-2D-restricted cytotoxic lymphocytes in the central nervous system of B10 mice. Virology 214:91-99.
23. Lipton, H. L. 1996. Theiler's viruses. In R. G. Webster and A. Granoff (ed.), Encyclopedia of virology plus CD-ROM product. Academic Press, London, England.
24. Lisak, R. P. 1980. Multiple sclerosis: evidence for immunopathogenesis. Neurology 30:99-105.
25. Mor, G., D. M. Klinman, S. Shapiro, E. Hagiwara, M. Sedegah, J. A. Norman, S. L. Hoffman, and A. D. Steinberg. 1995. Complexity of the cytokine and antibody response elicited by immunizing mice with Plasmodium yoelii circumsporozoite protein plasmid DNA. J. Immunol. 155:2039-2046.
26. Nelson, D. A. 1993. Dorsal root ganglia may be reservoirs of viral infection in multiple sclerosis. Med. Hypotheses 40:278-283.
27. Ohara, Y., S. Stein, J. Fu, L. Stillman, L. Klaman, and R. P. Roos. 1988. Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis viruses. Virology 164:245-255.
28. Pertmer, T. M., T. R. Roberts, and J. R. Haynes. 1996. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J. Virol. 70:6119-6125.
29. Poser, C. M. 1994. The epidemiology of multiple sclerosis: a general overview. Ann. Neurol. 36(Suppl. 2):S180-S193.
30. Prokudina, E. N., and N. P. Semenova. 1991. Localization of the influenza virus nucleoprotein: cell-associated and extracellular non-virion forms. J. Gen. Virol. 72:1699-1702.
31. Raine, C. S. 1994. The Dale E. McFarlin Memorial Lecture: the immunology of the multiple sclerosis lesion. Ann. Neurol. 36(Suppl.):S61-S72.
32. Rauch, H. C., I. N. Montgomery, C. L. Hinman, W. Harb, and J. A. Benjamins. 1987. Chronic Theiler's virus infection in mice: appearance of myelin basic protein in the cerebrospinal fluid and serum antibody directed against MBP J. Neuroimmunol. 14:35-48.
33. Rodriguez, M., L. R. Pease, and C. S. David. 1986. Immune-mediated injury of virus-infected oligodendrocytes: a model of multiple sclerosis. Immunol. Today 7:359-362.
34. Rodriguez, M., C. Rivera-Quińones, P. D. Murray, N. M. Kariuki, P. J. Wettstein, and T. Mak. 1997. The role of CD4+ and CD8+ T cells in demyelinating disease following Theiler's virus infection: a model for multiple sclerosis. J. Neurovirol. 3(Suppl. 1):S43-S45.
35. Roos, R. P., S. Stein, Y. Ohara, J. Fu, and B. L. Semler. 1989. Infectious cDNA clones of the DA strain of Theiler's murine encephalomyelitis virus. J. Virol. 63:5492-5496.
36. Rose, J., S. Gerken, S. Lynch, P. Pisani, T. Varvil, B. Otterud, and M. Leppert. 1993. Genetic susceptibility in familial multiple sclerosis not linked to the myelin basic protein gene. Lancet 341:1179-1181.
37. Sadovnick, A. D., and G. C. Ebers. 1997. Basic, clinical and genetic epidemiology of multiple sclerosis, p. 14-21. In O. Abramsky and H. Ovadia (ed.), Frontiers in multiple sclerosis: clinical research and therapy. Mosby-Year Book, St. Louis, Mo.
38. Schattner, A., and B. Rager-Zisman. 1990. Virus-induced autoimmunity. Rev. Infect. Dis. 12:204-222.
39. Seboun, E., J. R. Oksenberg, and S. L. Hauser. 1997. Molecular and genetic aspects of multiple sclerosis, p. 631-660. In R. N. Rosenberg, S. B. Prusiner, S. DiMauro, and R. L. Barchi (ed.), The molecular and genetic basis of neurological diseases. Butterworth-Heinemann, Newton, Mass.
40. Sibley, W. A., C. R. Bamford, and K. Clark. 1985. Clinical viral infections and multiple sclerosis. Lancet i:1313-1315.
41. Theil, D., and R. S. Fujinami. Unpublished data.
42. Torres, C. A., A. Iwasaki, B. H. Barber, and H. L. Robinson. 1997. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J. Immunol. 158:4529-4532.
43. Tsunoda, I., and R. S. Fujinami. 1996. Two models for multiple sclerosis: experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J. Neuropathol. Exp. Neurol. 55:673-686.
44. Tsunoda, I., and R. S. Fujinami. 1998. Theiler's murine encephalomyelitis virus (TMEV), p. 517-536. In R. Ahmed and I. Chen (ed.). Persistent viral infections. John Wiley & Sons, Chichester, England.
45. Tsunoda, I., V. Iwasaki, H. Terunuma, K. Sako, and Y. Ohara. 1996. A comparative study of acute and chronic diseases induced by two subgroups of Theiler's murine encephalomyelitis virus. Acta Neuropathol. (Berlin) 91: 595-602.
46. Tsunoda, I., L.-Q. Kuang, N. D. Tolley, J. L. Whitton, and R. S. Fujinami. 1998. Enhancement of experimental allergic encephalomyelitis (EAE) by DNA immunization with myelin proteolipid protein (PLP) plasmid DNA. J. Neuropathol. Exp. Neurol. 57:758-767.
47. Tsunoda, I., I. J. McCright, L.-Q. Kuang, A. Zurbriggen, and R. S. Fujinami. 1997. Hydrocephalus in mice infected with a Theiler's murine encephalomyelitis virus variant. J. Neuropathol. Exp. Neurol. 56:1302-1313.
48. Welsh, C. T., and R. S. Fujinami. 1996. Neuropathic viruses and autoimmunity, p. 159-180. In H. Friedman, N. R. Rose, and M. Bendinelli (ed.). Microorganisms and autoimmune diseases. Plenum Press, New York, N.Y.
49. Whitton, J. L., N. Sheng, M. B. Oldstone, and T. A. McKee. 1993 A "string-of-beads" vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge. J. Virol. 67:348-352.
50. Yamada, M., A. Zurbriggen, and R. S. Fujinami. 1990. Monoclonal antibody to Theiler's murine encephalomyelitis virus defines a determinant on myelin and oligodendrocytes, and augments demyelination in experimental allergic encephalomyelitis. J. Exp. Med. 171:1893-1907.
51. Yauch, R. L., K. Kerekes, K. Saujani, and B. S. Kim. 1995. Identification of a major T-cell epitope within VP3 amino acid residues 24 to 37 of Theiler's virus in demyelination-susceptible SJL/J mice. J. Virol. 69:7315-7318.
52. Yauch, R. L., and B. S. Kim. 1994. A predominant viral epitope recognized by T cells from the periphery and demyelinating lesions of SJL/J mice infected with Theiler's virus is located within VP1(233-244). J. Immunol. 153: 4508-4519.
53. Yokoyama, M., J. Zhang, and J. L. Whitton. 1995. DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J. Virol. 69:2684-2688.